HYFT - MindWalk Holdings, Inc. Average Forecast Price

Corporate company logo of MindWalk Holdings, Inc. (HYFT)

The daily price chart for MindWalk Holdings (HYFT) reflects the price action of an asset whose strategy relies on leasing third-party cloud capacity for software development. The business is building a complex predictive analysis environment for B2B data, creating high switching costs for customers. Revenue is generated from the implementation of IT tools in medicine and the creation of diagnostic algorithms, with the indicator standing at 4.30.

MindWalk Therapeutics (HYFT) - Consensus Target from 09/05/2025 to 11/12/2026
Flagship merchandise of MindWalk Therapeutics

A conservative investor evaluates MindWalk Holdings (HYFT) through the lens of fair value, excluding speculative noise. This metric aggregates average investment bank valuations to determine the equilibrium between market flows and fundamentals, which on the GURU.Markets platform reflects the trajectory of analysts' target prices. For an AI ecosystem with high customer switching costs, this indicator confirms the long-term capitalization of data network effects, protecting capital from overpayment.

Competitors of MindWalk Holdings

HLN (haleon.com) - Fair Value Consensus|Kenvue - Consensus Target|Verona Pharma PLC (VRNA) - Average Forecast Price|Jyong Biotech Corp - Analyst Consensus Forecast|Forecast Levels Chart LGND|AMRX (Amneal Pharmaceuticals) - Consensus Target|PRGO: Analyst Forecast Prices|Price Target Chart Alvotech SA|Liquidia Corp - Forecast Levels Chart|Analyst Consensus Forecast GLPG|ANIP (ANI Pharmaceuticals Corp) - Fair Value Consensus|Analyst Consensus Forecast MNKD (MannKind Corporation)|Analyst Consensus Forecast amphastar.com AMPH|PCRX - Price Target Chart|Fair Value Consensus SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Price Target Chart|Consensus Target Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Tectonic|Consensus Target TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Fair Value Consensus|Price Target Chart Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Average Forecast Price|EXOZ: Consensus Target|Oramed Pharmaceuticals - Analyst Forecast Prices|ENTX: Analyst Consensus Forecast|ABVC BioPharma Inc. - Fair Value Consensus|CPIX (Cumberland Pharma) - Analyst Consensus Forecast|Average Forecast Price Quantum BioPharma Corp QNTM|Price Target Chart FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Fair Value Consensus|Price Target Chart Rani Therapeutics Holdings, Inc. RANI|SNYR - Consensus Target|Rallybio Corp. - Analyst Consensus Forecast|Analyst Median Target Lexaria Bioscience LEXX|Pulmatrix, Inc. (PULM) - Price Target Chart|Broker Consensus Forecast PTHL|APM (Aptorum Group Ltd) - Analyst Consensus Forecast|Broker Consensus Forecast LYRA (Lyra Therapeutics Inc.)|Consensus Target IBO (Impact BioMedical Inc)|Consensus Target tnfpharma.com TNFA|Analyst Consensus Forecast YCBD (cbdMD)|Analyst Consensus Forecast painreform.com PRFX|CYTO - Price Target Chart|LIPO: Price Target Chart|Optinose (OPTN) - Price Target Chart|Pieris Pharma (PIRS) - Analyst Consensus Forecast|Consensus Target PROC|PTPI: Fair Value Consensus|Analyst Consensus Forecast QLI|SLRN (Acelyrin Inc.) - Fair Value Consensus|Price Target Chart TFF Pharma TFFP